Reactive arthritis is typically defined as an inflammatory arthritis not directly caused by
culture-proven infection of joint tissue, but rather after infection at another site. Historically …

Ankylosing spondylitis (AS) is a complex systemic rheumatological disease which often
causes severe disability and impaired quality of life (QoL). We searched the …

Objective To evaluate apremilast treatment in patients with active psoriatic arthritis, including
current skin involvement, despite prior therapy with conventional disease-modifying …

Abstract Introduction Psoriatic arthritis (PsA) is underdiagnosed and has a substantial impact
on quality of life, disability, and work productivity. The population-based Multinational …

Objective To evaluate the incidence, prevalence, characteristics, disease associations, risk
factors, and outcome of clinical enthesitis in patients with psoriatic arthritis (PsA). Methods …

Objectives To date, all studies addressing on anti-inflammatory drugs in PsA have been
carried out in psoriatic arthritis (PsA) patients with polyarticular disease. Specific studies on …

Objective To describe the prevalence of extra-articular manifestations—enthesitis, dactylitis,
nail disease, uveitis and IBD—in PsA, and their impact on longitudinal disease outcomes …

Objective. The Canadian Rheumatology Association (CRA) and the Spondyloarthritis
Research Consortium of Canada (SPARCC) have collaborated to update the …

Objective. Psoriatic arthritis (PsA) is a multifaceted disease. Affecting joints, skin, entheses,
and dactylitis, its effect on health-related quality of life (HRQOL) could be substantial. We …

This study aims to investigate how well the Assessment of SpondyloArthritis international
Society (ASAS)/Outcome Measures in Rheumatology Clinical Trials (OMERACT) core set …